Evaluation of Cefixime-Clavulanate Combination by Comparative Disk Diffusion Method in Klebsiella pneumoniae Clinical Isolates-An In-Vitro Study
Journal Title: Journal of Krishna Institute of Medical Sciences University - Year 2015, Vol 4, Issue 2
Abstract
Background: Resistance to cephalosporins due to β-lactamases is a major concern worldwide. However recent trend is to use β-lactamase inhibitor combinations. Potential combination is cefiximeclavulanate. Objective: Present study aims at the comparative evaluation of Fixed-Dose Combination (FDC) of cefixime‑clavulanate and cefixime-alone in Klebsiella pneumoniae clinical isolates. Material and Methods: Study included 200 clinical isolates of K. pneumoniae. The Comparative Antimicrobial Susceptibility Test (AST) of cefixime‑clavulanate (5µg/10µg) combination and cefixime-alone(5µg) was done by measurement and comparison of zone of lysis produced by both. All values were expressed in mean ± SD. Paired‘t’ test was used to determine statistical difference between different groups under study. P values < 0.05 were considered statistically significant. Isolates were tested for ExtendedSpectrum β-lactamase (ESBL), AmpC β-lactamase (AmpC) and metallo β-lactamase (MBL) production by Clinical Laboratory Standards Institute - Phenotypic Disk Confirmatory Test (CLSI-PDCT), AmpC β-lactamase sterile disk test and Imipenem-Ethylene Di-amine Tetracetic Acid – Double disk synergy test (Imipenem-EDTA DDST) respectively. Results: Comparative AST resulted in statistically significant (P < 0.001) increased zones in cefixime‑clavulanate combination than cefixime-alone in all isolates studied. When zones were evaluated separately only in three β-lactamase producing isolates; cefiximeclavulanate combination showed much higher zones in ESBL-producers (n=30) (P < 0.001), but not in AmpC-producers (n=32) (P = 0.5559) and MBLproducers (n=06) (P = 0.7815). Conclusion: Present study demonstrates the best bactericidal killing effect of cefixime-clavulanate compared to cefixime-alone. It is also of therapeutic significance in the treatment of infections caused by K. pneumoniae producing ESBLs. We recommend comparative AST method when commercially available newer β-lactamase inhibitor combination, for which no CLSI interpretive guidelines are available; to be studied systematically, before implementing it in treatment regimen.
Authors and Affiliations
Gajul S. V , Mohite S. T , Kakade S. V , Mangalagi S. S , Wavare S. M
Keywords
Related Articles
- EP ID EP105782
- DOI -
- Views 90
- Downloads 0
Seroprevalence of Toxoplasma gondii in Healthy Pregnant Women of Puducherry
-
Effectiveness of Pranayama on Depression in Elderly
The knowledge of Pranayama in elderly is very important in day to day life. In case of mental health problem like depression, the availability of the source of Complementary and Alternative Medicine (CAM) like Pranay...
Primary Hydatid Cyst of Thigh: A Case Report in Child
Hydatid cysts grow commonly in liver and lungs, but irregularly they are established in other sites. Occasionally few embryos run away the capillary filtrating systems of the liver and pulmonary and lead to hydatidosis o...
Prevalence of Self Medication in an Urban Slum Area in Maharashtra
Background: Self medication is defined asmedication taken on the patients own initiativeor on the advice of pharmacist or any other layperson. It is one of the leading causes for theever threatening drug resistance for...
Effect of Body Fat Distribution on Pulmonary Functions in Young Healthy Obese Students
Background: Obesity is defined as “abnormal or excessive fat accumulation that may impair health”. WHO defines obesity as Body Mass Index (BMI) ≥30 2 Kg/m . Obesity is becoming more prevalent in the world and has eff...